P130cas is a dominant tyrosine phosphorylated protein in v-src-and v-c
rk-transformed cells. Tyrosine phosphorylation also occurs in response
to integrin-mediated cell adhesion. P130cas has a unique structure,vi
th multiple SH2 and SH3 binding sites, which makes it a candidate, doc
king protein that might be involved in several signal transduction pat
hways. Little is known about how p130cas itself is regulated. In this
report we present evidence that tyrosine phosphorylated p130cas was ra
pidly dephosphorylated in several lymphatic cell lines after treatment
with calyculin A, a serine/threonine phosphatase inhibitor. A similar
result was obtained with okadaic acid, but higher concentrations and
longer incubation times were required, Constitutive phosphorylation as
well as receptor-cross linking-induced p130cas phosphorylation was in
hibited. Furthermore, the p130cas-Crk association was disrupted by tre
atment of cells with calyculin A. However, the p130cas-Lyn association
was not affected. These results suggest that calyculin A specifically
affects SH2 domain-mediated protein-protein interactions and that Lyn
does not bind to a susceptible SH2 domain. Furthermore, the data pres
ented is consistent with the existence of a calyculin A-sensitive phos
phatase or tyrosine kinase that may be a critical regulator of p130cas
tyrosine phosphorylation.